Merck KGaA family says unreservedly behind the pharma unit

DARMSTADT, Germany (Reuters) - The family behind Germany's Merck KGaA said it was fully committed to the group's pharmaceuticals unit, even if cancer immunotherapy hopeful avelumab does not achieve blockbuster sales.